INSMED Inc (INSM) stock
INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/30100% above fair value
$121.86−1.02 (-0.83%)
Close on Nov 17, 2026Market cap $26.73BP/E –Yield –
Insmed cash
Cash and short-term investments held at the end of each period.
Insmed's cash was $1.15B at Sep 30, 2026. For fiscal 2025 it was $1.43B, down 0.3% from the year before. Over ten years it grew 17.6% a year on average. The highest annual figure on record is $1.43B in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.43B | -0.3% |
| FY2024 | Dec 31, 2024 | $1.43B | +83.7% |
| FY2023 | Dec 31, 2023 | $780.45M | -32.0% |
| FY2022 | Dec 31, 2022 | $1.15B | +60.2% |
| FY2021 | Dec 31, 2021 | $716.78M | +34.5% |
| FY2020 | Dec 31, 2020 | $532.76M | +9.3% |
| FY2019 | Dec 31, 2019 | $487.43M | -1.5% |
| FY2018 | Dec 31, 2018 | $495.07M | +29.9% |
| FY2017 | Dec 31, 2017 | $381.17M | +134.4% |
| FY2016 | Dec 31, 2016 | $162.59M | -42.5% |
| FY2015 | Dec 31, 2015 | $282.88M | +77.7% |
| FY2014 | Dec 31, 2014 | $159.23M | +39.8% |
| FY2013 | Dec 31, 2013 | $113.89M | +25.5% |
| FY2012 | Dec 31, 2012 | $90.78M | +19.0% |
| FY2011 | Dec 31, 2011 | $76.27M | -29.4% |
| FY2010 | Dec 31, 2010 | $108.05M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.15B | -31.7% |
| Q2 FY2026 | Jun 30, 2026 | $1.16B | -37.5% |
| Q1 FY2026 | Mar 31, 2026 | $1.22B | +2.0% |
| Q4 FY2025 | Dec 31, 2025 | $1.43B | -0.3% |
| Q3 FY2025 | Sep 30, 2025 | $1.68B | +14.4% |
| Q2 FY2025 | Jun 30, 2025 | $1.86B | +48.9% |
| Q1 FY2025 | Mar 31, 2025 | $1.20B | +101.3% |
| Q4 FY2024 | Dec 31, 2024 | $1.43B | +83.7% |
| Q3 FY2024 | Sep 30, 2024 | $1.47B | +86.8% |
| Q2 FY2024 | Jun 30, 2024 | $1.25B | +35.9% |
| Q1 FY2024 | Mar 31, 2024 | $595.73M | -40.3% |
| Q4 FY2023 | Dec 31, 2023 | $780.45M | -32.0% |
| Q3 FY2023 | Sep 30, 2023 | $785.95M | +53.1% |
| Q2 FY2023 | Jun 30, 2023 | $917.77M | +65.4% |
| Q1 FY2023 | Mar 31, 2023 | $998.68M | +57.2% |
| Q4 FY2022 | Dec 31, 2022 | $1.15B | +60.2% |
| Q3 FY2022 | Sep 30, 2022 | $513.30M | -39.4% |
| Q2 FY2022 | Jun 30, 2022 | $554.87M | -40.2% |
| Q1 FY2022 | Mar 31, 2022 | $635.12M | +55.0% |
| Q4 FY2021 | Dec 31, 2021 | $716.78M | +34.5% |
| Q3 FY2021 | Sep 30, 2021 | $846.56M | +43.8% |
| Q2 FY2021 | Jun 30, 2021 | $928.33M | +44.6% |
| Q1 FY2021 | Mar 31, 2021 | $409.75M | -4.5% |
| Q4 FY2020 | Dec 31, 2020 | $532.76M | +9.3% |
| Q3 FY2020 | Sep 30, 2020 | $588.75M | +9.9% |
| Q2 FY2020 | Jun 30, 2020 | $641.91M | +6.8% |
| Q1 FY2020 | Mar 31, 2020 | $428.94M | +2.1% |
| Q4 FY2019 | Dec 31, 2019 | $487.43M | -1.5% |
| Q3 FY2019 | Sep 30, 2019 | $535.63M | -5.6% |
| Q2 FY2019 | Jun 30, 2019 | $601.26M | -5.2% |
| Q1 FY2019 | Mar 31, 2019 | $420.23M | -38.8% |
| Q4 FY2018 | Dec 31, 2018 | $495.07M | +29.9% |
| Q3 FY2018 | Sep 30, 2018 | $567.57M | +31.8% |
| Q2 FY2018 | Jun 30, 2018 | $634.33M | +596.6% |
| Q1 FY2018 | Mar 31, 2018 | $686.58M | +445.6% |
| Q4 FY2017 | Dec 31, 2017 | $381.17M | +134.4% |
| Q3 FY2017 | Sep 30, 2017 | $430.68M | – |
| Q2 FY2017 | Jun 30, 2017 | $91.06M | – |
| Q1 FY2017 | Mar 31, 2017 | $125.84M | – |
| Q4 FY2016 | Dec 31, 2016 | $162.59M | – |
See a number that looks wrong?